4.6 Article

Cathepsin E: A novel target for regulation by class II transactivator

Journal

JOURNAL OF IMMUNOLOGY
Volume 172, Issue 9, Pages 5528-5534

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.172.9.5528

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [AI056097, AI53556, AI41510] Funding Source: Medline
  2. NIDDK NIH HHS [DK58771] Funding Source: Medline

Ask authors/readers for more resources

The aspartic proteinase cathepsin E (CatE) has been implicated in Ag processing. In this study we report that CatE expression is negatively regulated by the MHC class II transactivator (CIITA). CIITA-deficient murine and human B cells expressed greater CatE than wild-type B cells, whereas overexpression of CIITA in a human gastric carcinoma cell line, AGS, resulted in decreased CatE mRNA and protein. AGS cells expressing CIITA also exhibited decreased processing of OVA Ag. Inhibition of CatE expression is specific to the type III CIITA isoform and maps to the acidic and proline/serine/threonine-rich (PST) protein domains of CIITA. We found that CatE expression is inducible by PU.1 and p300, and that this induction can be reversed by CIITA. These findings demonstrate a novel phenomenon: regulation of CatE Ag processing by CIITA in an isoform-dependent manner.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available